The Genomic Landscape of Thyroid Cancer Tumourigenesis and Implications for ImmunotherapyAmandeep Singh, Cheok Soon Lee, Jeehoon Ham et al.|Cells|2021Cited by 82
Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 Expression in Patients with Non-Medullary Thyroid Cancer: A Systematic Review and Meta-AnalysisMarra Aghajani, Navin Niles, Susannah Graham et al.|Thyroid|2018Cited by 45
Pembrolizumab for anaplastic thyroid cancer: a case studyMarra Aghajani, Tara L. Roberts, Helen M. McGuire et al.|Cancer Immunology Immunotherapy|2019Cited by 30
Elevated levels of soluble PD-L1 are associated with reduced recurrence in papillary thyroid cancerMarra Aghajani, Navin Niles, Tara L. Roberts et al.|Endocrine Connections|2019Cited by 28
Epithelial-to-mesenchymal transition and its association with PD-L1 and CD8 in thyroid cancerMarra Aghajani, Tara L. Roberts, Tao Yang et al.|Endocrine Connections|2020Cited by 16